TAC1 Gene

TAC1 (Tachykinin Precursor 1)

Introduction

The TAC1 gene (Tachykinin Precursor 1) encodes the precursors for substance P (SP) and neurokinin A (NKA), two important neuropeptides that play critical roles in pain transmission, neuroinflammation, and neurodegenerative disease pathogenesis. Located on chromosome 7q21-q22, TAC1 produces multiple tachykinin peptides through alternative splicing and post-translational processing. This gene has emerged as a significant player in Alzheimer's disease, Parkinson's disease, and other neurodegenerative disorders[@raddatz2008].

The tachykinin system represents one of the oldest neuropeptide systems in evolution. In humans, TAC1-derived peptides exert their effects through three neurokinin receptors (NK1, NK2, NK3), which belong to the G protein-coupled receptor (GPCR) superfamily. The widespread distribution of these receptors throughout the central and peripheral nervous systems explains the diverse biological functions of tachykinins[@barker2015].

TAC1 (Tachykinin Precursor 1)

Introduction

The TAC1 gene (Tachykinin Precursor 1) encodes the precursors for substance P (SP) and neurokinin A (NKA), two important neuropeptides that play critical roles in pain transmission, neuroinflammation, and neurodegenerative disease pathogenesis. Located on chromosome 7q21-q22, TAC1 produces multiple tachykinin peptides through alternative splicing and post-translational processing. This gene has emerged as a significant player in Alzheimer's disease, Parkinson's disease, and other neurodegenerative disorders[@raddatz2008].

The tachykinin system represents one of the oldest neuropeptide systems in evolution. In humans, TAC1-derived peptides exert their effects through three neurokinin receptors (NK1, NK2, NK3), which belong to the G protein-coupled receptor (GPCR) superfamily. The widespread distribution of these receptors throughout the central and peripheral nervous systems explains the diverse biological functions of tachykinins[@barker2015].

<div class="infobox infobox-gene">
<table>
<tr><th>Gene Symbol</th><td>TAC1</td></tr>
<tr><th>Full Name</th><td>Tachykinin Precursor 1</td></tr>
<tr><th>Chromosomal Location</th><td>7q21-q22</td></tr>
<tr><th>NCBI Gene ID</th><td><a href="https://www.ncbi.nlm.nih.gov/gene/6863" target="_blank">6863</a></td></tr>
<tr><th>OMIM</th><td><a href="https://www.omim.org/entry/162330" target="_blank">162330</a></td></tr>
<tr><th>Ensembl ID</th><td>ENSG00000125037</td></tr>
<tr><th>UniProt ID</th><td><a href="https://www.uniprot.org/uniprot/P20333" target="_blank">P20333</a></td></tr>
<tr><th>Associated Diseases</th><td>[Alzheimer's Disease](/diseases/alzheimers-disease), [Parkinson's Disease](/diseases/parkinsons-disease), [Depression](/diseases/depression)</td></tr>
</table>
</div>

Gene Structure and Alternative Splicing

Genomic Organization

The TAC1 gene spans approximately 8.5 kb on chromosome 7q21-q22 and consists of 7 exons. Alternative splicing generates multiple mRNA variants encoding different preprotachykinin isoforms:

• Type A preprotachykinin: Contains substance P and neurokinin A
• Type B preprotachykinin: Encodes only neurokinin A
• Type C preprotachykinin: Contains non-tachykinin sequence

Protein Processing

TAC1 undergoes extensive post-translational processing to generate active peptides:

preprotachykinin A (381 aa)
→ signal peptide cleavage
proprotachykinin (357 aa)
→ paired basic amino acid cleavage + amidation
substance P (11 aa): RPKPQQFFGLM-NH2
neurokinin A (10 aa): HKTYKSVGLM-NH2

Tachykinin Receptors

| Receptor | Primary Ligand | Distribution | Signaling |
|----------|--------------|-------------|-----------|
| NK1 (TACR1) | Substance P | Brain, spinal cord | Gq/11 → PLC |
| NK2 (TACR2) | Neurokinin A | Smooth muscle, CNS | Gq/11 → PLC |
| NK3 (TACR3) | Neurokinin B | CNS (interneurons) | Gq/11 → PLC |

Expression in the Brain

TAC1-derived peptides are widely distributed in the central nervous system:

• Substantia nigra: Moderate expression in dopaminergic neurons[@yaus2012]
• Striatum: High expression in medium spiny neurons
• Hypothalamus: Strong expression in paraventricular nucleus
• Amygdala: Moderate expression in central nucleus
• Dorsal root ganglion: High expression in sensory neurons
• Spinal cord: Highest expression in laminae I-II of dorsal horn

Role in Alzheimer's Disease

Substance P and the TAC1-derived peptides play complex roles in Alzheimer's disease pathogenesis[@tooyama2010]:

Amyloid Metabolism

• Substance P can modulate amyloid precursor protein (APP) processing
• NK1 receptor activation influences β-secretase activity
• Aβ exposure increases tachykinin expression

Tau Pathology

• Substance P receptors colocalize with neurofibrillary tangles
• SP signaling influences tau phosphorylation
• NK1 antagonists reduce tau pathology[@song2017]

Neuroinflammation

Substance P potently promotes neuroinflammation through microglia activation[@wang2019]:

NK1 receptor antagonists have shown promise in AD models: reduced amyloid plaque load, decreased neuroinflammation, improved cognitive performance[@zhang2023].

Role in Parkinson's Disease

The TAC1 system is significantly altered in Parkinson's disease[@yaus2012]:

Substantia Nigra Alterations

• Decreased substance P in PD substantia nigra
• Loss of tachykininergic striatal neurons
• Correlation with Lewy body pathology

Alpha-Synuclein Interactions

Recent studies suggest interactions between substance P and alpha-synuclein[@zhou2020]:

• SP may promote alpha-synuclein aggregation
• NK1 activation increases oxidative stress
• Potential for NK1-targeted interventions

Signaling Pathways

Substance P activates multiple intracellular signaling cascades through NK1 receptor:

Therapeutic Targeting

NK1 Receptor Antagonists

The tachykinin system offers multiple therapeutic intervention points:

• Aprepitant: FDA-approved for chemotherapy nausea
• Novel NK1 antagonists in development for neurodegeneration
• Reduced amyloid burden and neuroinflammation in models

Novel Approaches

• Anti-substance P antibodies
• Peptide-based NK1 agonists
• Gene therapy with TAC1 RNAi

See Also

• [Neuroinflammation](/mechanisms/neuroinflammation)
• [TAC1 Protein](/proteins/tac1-protein)
• [Tachykinin Signaling](/mechanisms/tachykinin-signaling)
• [Alzheimer's Disease](/diseases/alzheimers-disease)
• [Parkinson's Disease](/diseases/parkinsons-disease)

References

Pathway Diagram

The following diagram shows the key molecular relationships involving TAC1 Gene discovered through SciDEX knowledge graph analysis: